Dr. Velaphi Thipe
Research & Development

Frontiers of
Discovery.

Merging the precision sustainability of green chemistry to redefine cancer therapeutics and global health solutions.

Green Nanomedicine

Pioneering the synthesis of biocompatible nanoparticles using phytochemicals from medicinal plants, completely eliminating toxic reducing agents.

Targeted Green Nanotherapies

Advancing environmentally responsible nanotherapeutic agents engineered for selective tumor uptake and improved therapeutic index, with minimal impact on healthy tissue.

Immunomodulation

Validating novel nanotherapeutic strategies to reprogram the tumor microenvironment, shifting pro-tumor M2 macrophages to anti-tumor M1 phenotypes.

Scientific Economics

Integrating rigorously validated science with business analytics to ensure scalability, market viability, and sustainable healthcare impact.

The Green
Methodology

We utilize a proprietary "Green Chemistry" approach that leverages the potent antioxidant properties of natural phytochemicals to reduce metal salts into therapeutic nanoparticles. This eliminates the need for toxic chemicals, resulting in highly biocompatible agents suitable for clinical translation.

Zero-Toxic Synthesis

No harsh chemicals used in production.

Targeted Delivery

Precision homing to cancer cell receptors.

Theranostic Capability

Simultaneous imaging and therapy.

Scalable Manufacturing

Process designed for industrial adoption.

Current Clinical Targets

Prostate CancerPancreatic CancerTriple-Negative Breast CancerOvarian CancerMycotoxin Mitigation